Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 947K 896K 813K 1.52M 103M 1.54M 10.75M 4.14M 52.61M 4.03M 3.94M 169M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 730K 690K 626K 1.17M 79.32M 1.19M 8.28M 3.19M 40.5M 3.1M 3.04M 130M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 week-85.73%
Current month-85.73%
1 month-85.73%
3 months-85.71%
6 months-80.00%
Current year-66.67%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-85.73%-.--%-99.55% 26.4K
-0.14%+2.53%-0.78%+61.71% 3,781B
-0.53%+0.49%+3.94%+1,061.91% 451B
-0.03%+7.98%+83.96%+193.36% 96.48B
-0.82%+6.73%-7.22%+38.00% 89.97B
-0.82%+1.04%-14.14%-9.91% 80.03B
-0.41%-4.85%-45.64%+124.45% 60.58B
-1.43%-6.98%+6.16%-12.91% 45.2B
-0.49%+1.87%+177.92%+395.20% 44.07B
+0.53%-1.41%-22.05%+44.34% 37.84B
Average -0.62%+3.30%+18.21%+179.66% 468.59B
Weighted average by Cap. -0.25%+2.06%+2.06%+161.99%

Financials

2015 2016
Net sales 4.22M 3.73M 3.53M 3.2M 5.99M 405M 6.05M 42.29M 16.3M 207M 15.85M 15.51M 666M 3.04M 2.69M 2.54M 2.31M 4.32M 292M 4.37M 30.5M 11.76M 149M 11.43M 11.19M 480M
Net income 151K 133K 126K 114K 214K 14.49M 216K 1.51M 583K 7.4M 567K 555K 23.81M -344K -304K -287K -260K -488K -33.01M -493K -3.45M -1.33M -16.86M -1.29M -1.26M -54.24M
Net Debt -340K -300K -284K -257K -483K -32.63M -487K -3.41M -1.31M -16.66M -1.28M -1.25M -53.61M -247K -218K -206K -187K -351K -23.7M -354K -2.47M -954K -12.1M -927K -907K -38.95M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock